This is a paid press release. Contact the press release distributor directly with any inquiries.
Laser Photonics Announces Exercise of Warrants for $2.5 Million Gross Proceeds
Laser Photonics Corp.
Fri, July 17, 2026 at 5:30 PM GMT+5:30
3 min read
- LASE
-20.22%
ORLANDO, FL /ACCESS Newswire/ July 17, 2026 /Laser Photonics Corporation (NASDAQ:LASE) (the “Company”), a global leader in laser systems for industrial and defense applications, today announced the entry into definitive agreements for the immediate exercise of certain outstanding warrants to purchase up to an aggregate of 2,528,572 shares of common stock of the Company originally issued in April 2026, having an exercise price of $0.975 per share. The shares of common stock issuable upon exercise of the warrants are registered pursuant to an effective registration statement on Form S-1 (No. 333-297400). The gross proceeds to the Company from the exercise of the warrants are expected to be approximately $2.5 million, prior to deducting placement agent fees and estimated offering expenses.
H.C. Wainwright & Co. is acting as the exclusive placement agent for the offering
In consideration for the immediate exercise of the warrants for cash, the Company will issue new unregistered Series A-7 warrants to purchase up to 800,000 shares of common stock and new unregistered Series A-8 warrants to purchase up to 4,257,144 shares of common stock. The new warrants will have an exercise price of $0.975 per share and will be exercisable immediately upon issuance. The Series A-7 new warrants will expire five years after the effective date of the Resale Registration Statement (as defined below) and the Series A-8 new warrants will expire twenty-four months after the effective date of the Resale Registration Statement.
The offering is expected to close on or about July 20, 2026, subject to satisfaction of customary closing conditions. The Company intends to use the net proceeds from the offering for working capital and general corporate purposes
The new warrants described above were offered in a private placement pursuant to an applicable exemption from the registration requirements of the Securities Act of 1933, as amended (the “1933 Act”) and, along with the shares of common stock issuable upon their exercise, have not been registered under the 1933 Act, and may not be offered or sold in the United States absent registration with the Securities and Exchange Commission (“SEC”) or an applicable exemption from such registration requirements. The Company has agreed to file a registration statement with the SEC covering the resale of the shares of common stock issuable upon exercise of the new warrants (the “Resale Registration Statement”).
This press release shall not constitute an offer to sell or a solicitation of an offer to buy nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to the registration or qualification under the securities laws of any such state or jurisdiction
